Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
3(21%)
Results Posted
14%(1 trials)

Phase Distribution

Ph phase_4
1
7%
Ph not_applicable
1
7%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

3

trials recruiting

Total Trials

14

all time

Status Distribution
Active(4)
Completed(7)
Terminated(1)
Other(2)

Detailed Status

Completed7
Recruiting3
unknown2
Withdrawn1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (50.0%)
N/A1 (50.0%)

Trials by Status

withdrawn17%
recruiting321%
unknown214%
completed750%
enrolling_by_invitation17%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
14